These findings implicate genes that may regulate immune response and inflammation in AF, emerging as risk factors for arrhythmic disease19, and support a potential role for SRC, which has been proposed as a promising target in other cardiovascular diseases20. The gene discussed is SRC; the disease is atrial fibrillation.